Congestive Heart Failure

Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology
Cover of the book Congestive Heart Failure by J. Morganroth, E. Neil Moore, Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: J. Morganroth, E. Neil Moore ISBN: 9781461320777
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author: J. Morganroth, E. Neil Moore
ISBN: 9781461320777
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues to remain dismal wi th less than a 50% expected five year survival. In the last decade we have seen many new medical and therapeutic options for patients with congestive heart failure which extend beyond the use of bed rest, sodium restriction, digitalis and diuretics. These include vasodilators of a variety of types including the angiotensin conventional enzyme (ACE) inhibitors. Also, many new inotropes are under active investigation both in oral and intravenous forms. In March of 1984 a survey of over 5000 physicians was performed under the auspices of the American Heart Association (reported in: JAOC 8:966, 1986). That survey showed that there was no universally accepted defini tion for congestive heart fai lure and that a wide spectrum of diagnostic cri teria for this common condi tion existed even among academic cardiologists. There was no clear standard as to even the mos t bas ic treatment of conges t i ve heart fai lure. For example, exercise restriction was recommended by 19% of physicians, 31% recommended no change in activity, and 50% either light exercise or an exercise conditioning program.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition of this condition and active medical research into both mechanisms and therapy, prognosis continues to remain dismal wi th less than a 50% expected five year survival. In the last decade we have seen many new medical and therapeutic options for patients with congestive heart failure which extend beyond the use of bed rest, sodium restriction, digitalis and diuretics. These include vasodilators of a variety of types including the angiotensin conventional enzyme (ACE) inhibitors. Also, many new inotropes are under active investigation both in oral and intravenous forms. In March of 1984 a survey of over 5000 physicians was performed under the auspices of the American Heart Association (reported in: JAOC 8:966, 1986). That survey showed that there was no universally accepted defini tion for congestive heart fai lure and that a wide spectrum of diagnostic cri teria for this common condi tion existed even among academic cardiologists. There was no clear standard as to even the mos t bas ic treatment of conges t i ve heart fai lure. For example, exercise restriction was recommended by 19% of physicians, 31% recommended no change in activity, and 50% either light exercise or an exercise conditioning program.

More books from Springer US

Cover of the book Legacy of Injustice by J. Morganroth, E. Neil Moore
Cover of the book Aging and Neuropsychological Assessment by J. Morganroth, E. Neil Moore
Cover of the book Bladder Disease by J. Morganroth, E. Neil Moore
Cover of the book The Year in Metabolism 1975–1976 by J. Morganroth, E. Neil Moore
Cover of the book Cryopreservation and low temperature biology in blood transfusion by J. Morganroth, E. Neil Moore
Cover of the book Biofeedback by J. Morganroth, E. Neil Moore
Cover of the book On-Chip Instrumentation by J. Morganroth, E. Neil Moore
Cover of the book Ion/Molecule Attachment Reactions: Mass Spectrometry by J. Morganroth, E. Neil Moore
Cover of the book Trends in Youth Development by J. Morganroth, E. Neil Moore
Cover of the book Methods in DNA Amplification by J. Morganroth, E. Neil Moore
Cover of the book Human in Vitro Fertilization and Embryo Transfer by J. Morganroth, E. Neil Moore
Cover of the book The Juvenile Offender by J. Morganroth, E. Neil Moore
Cover of the book Psychiatric Consequences of Brain Disease in the Elderly: A Focus on Management by J. Morganroth, E. Neil Moore
Cover of the book Apple IIc and IIe Assembly Language by J. Morganroth, E. Neil Moore
Cover of the book Cross-Linguistic Study of Acquired Reading Disorders by J. Morganroth, E. Neil Moore
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy